Transcript | Gene array (CFC) | R-NTR | Â |
|---|
ITGA2 | −2.5 (p < 0.05) | 5.4-fold | (p = 0.063, s.n.s.) |
ITGA4 | −12.4 (p < 0.0001) | 2-fold | (p < 0.0006) |
ITGA6 | −19.3 (p < 0.0001) | 3.3-fold | (p < 0.005) |
ITGA7 | +6.8 (p < 0.0001) | 0.007-fold | (p < 0.0001) |
ITGA11 | +4.6 (p < 0.0006) | 0.2-fold | (p < 0.41, s.n.s.) |
- The table documents the differences in integrin transcript expression between bone marrow-derived mesenchymal stromal cells (bmMSCs) and term placenta-derived mesenchymal stromal cells (pMSCs) as evaluated by gene array (CFC; left, n ≥ 6 RNA samples each) or quantitative reverse transcription polymerase chain reaction (R-NTRs; right, n ≥ 4 cDNA samples each). CFC-values v > 1 denominate a higher, values v < 1 a lower expression in bmMSCs, respectively (CFC: combined fold change of transcripts enumerated by gene array, after evaluation with FDR corrections). R-NTR ratio of normalized transcript rates, s.n.s. statistically not significant
